Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Pfizer's Phase 1 study PF-08046876 is recruiting adults with various advanced solid tumors to evaluate safety and dosing. The trial includes bladder cancer, uro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Esophageal Adenocarcinoma
• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma
• Gastroesophageal Junction Adenocarcinoma
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Urothelial Carcinoma

Drugs mentioned

• PF-08046876

Snippet

Sponsor: Pfizer | Conditions: Advanced/Metastatic Solid Tumors, Bladder Cancer | Phase 1 | Status: RECRUITING